Cargando…

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes

Detalles Bibliográficos
Autor principal:	Oh, Jee-Young
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883355/ https://www.ncbi.nlm.nih.gov/pubmed/20548839 http://dx.doi.org/10.4093/kdj.2010.34.2.84

Ejemplares similares

Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients
por: Kim, Eun Hee, et al.
Publicado: (2010)

Serum cystatin C and neutrophil gelatinase-associated lipocalin in predicting the severity of coronary artery disease in diabetic patients
por: Okyay, Kaan, et al.
Publicado: (2016)

Clinical Utility of Serum Cystatin C in Predicting Coronary Artery Disease in Patients Without Chronic Kidney Disease
por: Dandana, Azza, et al.
Publicado: (2014)

Cystatin C Is Not Causally Related to Coronary Artery Disease
por: Svensson-Färbom, Patrik, et al.
Publicado: (2015)

Cystatin C as a Promising Biomarker of Atherosclerotic Plaque
por: Sawada, Shojiro
Publicado: (2021)

Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion
por: Shen, Ying, et al.
Publicado: (2015)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease
por: Doğaner, Yusuf Çetin, et al.
Publicado: (2015)

Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome
por: Dong, Hao, et al.
Publicado: (2023)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
por: Nagy, Előd Ernő, et al.
Publicado: (2022)

Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate
por: Pan, Junqiang, et al.
Publicado: (2021)

Discrepant changes of urinary cystatin C and other urinary biomarkers in preterm neonates()
por: Filler, Guido, et al.
Publicado: (2021)

Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19
por: Miyata, Yoshito, et al.
Publicado: (2022)

Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients
por: Stankute, Ingrida, et al.
Publicado: (2022)

A New Perspective for Isolated Coronary Artery Ectasia: Cystatin C
por: Karakus, Alper, et al.
Publicado: (2020)

Letter: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100)
por: Won, Kyu-Chang
Publicado: (2010)

Response: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100)
por: Kim, Eun Hee, et al.
Publicado: (2010)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

The Predictability of Cystatin C for Peripheral Arterial Disease in Chinese Population with Type 2 Diabetes Mellitus
por: Liu, Luna, et al.
Publicado: (2022)

Serum Cystatin C Reflects the Progress of Albuminuria
por: Yoo, Jeong Seon, et al.
Publicado: (2011)

Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
por: Wang, Nana, et al.
Publicado: (2022)

Serum neutrophil gelatinase-associated lipocalin and cystatin C are diagnostic markers of renal dysfunction in older patients with coronary artery disease
por: Zhu, Hong, et al.
Publicado: (2018)

Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions
por: Wang, Zheng-Yu, et al.
Publicado: (2020)

Cystatin C in Acute Coronary Syndrome
por: Lodh, Moushumi, et al.
Publicado: (2013)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
por: Wong, Chee Wai, et al.
Publicado: (2015)

Cystatin C as a Predictor for Diabetes according to Glycosylated Hemoglobin Levels in Korean Patients
por: Jeon, Eon Ju, et al.
Publicado: (2016)

The potential of cystatin C as a predictive biomarker in pulmonary hypertension
por: Duan, Anqi, et al.
Publicado: (2023)

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2011)

Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors
por: Wang, Hui, et al.
Publicado: (2018)

Correlation Analysis and Diagnostic Value of Serum Homocysteine, Cystatin C and Uric Acid Levels with the Severity of Coronary Artery Stenosis in Patients with Coronary Heart Disease
por: Gao, Yang, et al.
Publicado: (2023)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Hammouda, Nada E., et al.
Publicado: (2017)

Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus
por: Assal, Heba S., et al.
Publicado: (2013)

Cystatin C: not just a marker of kidney function
por: Fernando, Sanduni, et al.
Publicado: (2020)

Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients
por: Nakamura, Tsutomu, et al.
Publicado: (2006)

Endostatin and Cystatin C as Potential Biomarkers for Early Prediction of Preeclampsia
por: Alshannag, Fatima, et al.
Publicado: (2023)

Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022)

Clinical utility of serum cystatin C for prediction of multi-vessel disease by coronary angiography in type 2 diabetes mellitus patients with normal renal function
por: Wang, Shaoyi, et al.
Publicado: (2020)

Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis
por: Benndorf, Ralf A.
Publicado: (2018)

Cystatin C may not be a precious predictor for coronary artery disease and its severity: an area of uncertainty
por: Vakili, Hossein, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hsiuinmq955l74jqm3ns1rkro